ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
14
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,509
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Efficacy and safety of once-daily lixisenatide in type 2 diabetes insufficiently controlled with basal insulin ± metformin: GetGoal-L study
Author(s):
P. Home
,
M Riddle
,
K. R. Aronson
Publication date:
2012
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cardiovascular Innovations and Applications
Data availability:
ScienceOpen disciplines:
Medicine
,
Cardiovascular Medicine
Comments
Comment on this article
Sign in to comment
Similar content
2,509
P1130 Efficacité et tolérance du lixisénatide chez le sujet diabétique de type 2 âgé (≥ 65 ans) et très âgé (≥ 75 ans) : analyse des essais de phase III GetGoal
Authors:
D Raccah
,
P Miossec
,
V. Esposito
…
Efficacy and safety of lixisenatide once daily versus placebo in patients with type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P) [Abstract]
Authors:
M Pinget
,
R Goldenberg
,
E Niemoeller
…
Efficacy and safety of lixisenatide in elderly ($65 yr) and very elderly ($75 yr) patients with type 2 diabetes: an analysis from the GetGoal Phase 3 program
Authors:
D Raccah
,
P Miossec
,
V. Esposito
…
See all similar